Status:
RECRUITING
"Studying The Role of Key Epigenetic Mediators in Breast Cancer Patients"
Lead Sponsor:
Ain Shams University
Conditions:
Breast Cancer
Eligibility:
FEMALE
18+ years
Brief Summary
The role of epigenetic regulators and their dysregulation in cancer have gained much attention recently, as they influence the gene expression of many oncogenes and tumor suppressor genes. Non-coding ...
Detailed Description
Breast cancer is considered as one of the most frequent malignancies in women worldwide and one of the leading cause of death among women globally. Even with remarkable advances in diagnosis and thera...
Eligibility Criteria
Inclusion Criteria: Egyptian females breast cancer patients aged 18 years and above, newly diagnosed with breast cancer.
Exclusion Criteria: Blood diseases, any cancer other than breast cancer, liver cirrhosis and uterine and urinary bladder diseases or breast cancer patients with any evidence of distant metastases.
Key Trial Info
Start Date :
November 23 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06759714
Start Date
November 23 2024
End Date
December 1 2025
Last Update
January 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of pharmacy, Ain Shams University
Cairo, Egypt